NanoViricides
NNVC
#10561
Rank
โ‚น3.19 B
Marketcap
โ‚น124.91
Share price
0.76%
Change (1 day)
-16.13%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2023 (TTM): -โ‚น47.98

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น41.32. In 2022 the company made an earnings per share (EPS) of -โ‚น56.35 an increase over its 2021 EPS that were of -โ‚น72.32.

EPS history for NanoViricides from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น47.98-14.86%
2022-โ‚น56.35-22.08%
2021-โ‚น72.32-52.47%
2020-โ‚น152.15-22.12%
2019-โ‚น195.35-5.88%
2018-โ‚น207.56-30.94%
2017-โ‚น300.54-20%
2016-โ‚น375.68111.85%
2015-โ‚น177.34-27.38%
2014-โ‚น244.19-55.17%
2013-โ‚น544.7456.76%
2012-โ‚น347.5015.63%
2011-โ‚น300.54-8.57%
2010-โ‚น328.7266.67%
2009-โ‚น197.2315.38%
2008-โ‚น170.93-21.67%
2007-โ‚น218.21-17.02%
2006-โ‚น262.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-โ‚น291.15 604.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น93.24-325.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น424.52-1,127.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น270.24-753.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น142.76 245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น135.24 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA